Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
Breast Cancer Res. Treat., Sep (2012)
Biologic markers determine both the risk and the timing of recurrence in breast cancer.
Breast Cancer Res. Treat., Sep;129(2):607-16 (2011)
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial).
Breast Cancer Res. Treat., Apr;132(3):871-9 (2012)
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ.
Breast., Dec;20(6):529-33 (2011)
Accelerating identification and regulatory approval of investigational cancer drugs.
JAMA., Dec;306(23):2608-9 (2011)
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Breast Cancer Res. Treat., Apr;132(3):1049-62 (2012)
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.
J. Exp. Med., Apr;209(4):679-96 (2012)
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Radiology., Jun;263(3):663-72 (2012)
Leukocyte composition of human breast cancer.
Proc. Natl. Acad. Sci. U.S.A., Feb;109(8):2796-801 (2012)
A comparison of RNA amplification techniques at sub-nanogram input concentration.
BMC Genomics., 10:326 (2009)
Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer.
Breast J., 15(3):242-6 (2009)
Application of screening principles to the reconstructed breast.
J. Clin. Oncol., Jan;28(1):173-80 (2010)
Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction.
Arch Surg., Sep;145(9):880-5 (2010)
Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.
Expert Rev. Mol. Diagn., Jan;11(1):91-100 (2011)
Breast cancer growth prevention by statins.
Cancer Res., Sep;66(17):8707-14 (2006)
Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
Cancer., Jun;111(3):185-91 (2007)
Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer.
J. Clin. Oncol., Aug;25(24):3680-7 (2007)
A role for biomarkers in the screening and diagnosis of breast cancer in younger women.
Expert Rev. Mol. Diagn., Sep;7(5):533-44 (2007)
Optimizing the total skin-sparing mastectomy.
Arch Surg., Jan;143(1):38-45; discussion 45 (2008)
Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.
Radiology., Jul;248(1):79-87 (2008)